Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avid Bioservices Inc (NQ: CDMO )

9.440 -0.280 (-2.88%)
Official Closing Price Updated: 4:15 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avid Bioservices Inc

< Previous 1 2 3 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
Earnings Scheduled For September 7, 2023
Companies Reporting Before The Bell • Tsakos Energy Navigation (NYSE:TNP) is likely to report quarterly earnings at $1.60 per share on revenue of $174.10 million. 
Via Benzinga
Earnings Outlook For Avid Bioservices
Via Benzinga
Why Avid Bioservices Stock Was Plummeting This Week
The specialty healthcare services provider had a fiscal fourth quarter to forget. 
Via The Motley Fool
Why Shares of Avid Bioservices Are Dropping Thursday
The CDMO released fourth-quarter and fiscal 2023 earnings. 
Via The Motley Fool
Avid Bioservice's FY24 Shortfall Anticipated: Analyst Says Later Stage Backlog May Pay In Longer Run
Wednesday afternoon Avid Bioservices Inc (NASDAQ: CDMO) reported Q4 revenue of $39.8 million, a 28% Y/Y, beating the co 
Via Benzinga
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to... 
Via Benzinga
Tech-Heavy Nasdaq Firmly Higher Midday
Stocks are attempting a rebound this afternoon, following their third-straight day of losses. 
Via Talk Markets
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P... 
Via Benzinga
Avid Bioservices's Return on Invested Capital Overview
Via Benzinga
Earnings Preview For Avid Bioservices
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
US Stocks Lower Following Initial Jobless Claims Report
U.S. stocks traded lower this morning, with Nasdaq Composite dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.16% to 33,895.80 while the NASDAQ fell... 
Via Benzinga
Avid Bioservices Inc. (NASDAQ: CDMO) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Why Avid Bioservices Stock Is Surging Today
The bio-manufacturer's ongoing expansion efforts are a hit with investors. 
Via The Motley Fool
Avid Bioservices Earnings Preview
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For June 21, 2023
Companies Reporting Before The Bell • iHuman (NYSE:IH) is projected to report earnings for its first quarter. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Dow Extends Rebound, Surges 456 Points
Rallying bank stocks are fueling Wall Street's midday gains, as investors continue to unpack this morning's consumer price index (CPI) data. 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodies, 
Via MarketBeat
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a... 
Via Benzinga
First Republic Bank, PacWest Bancorp, Western Alliance Bancorporation And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Nasdaq Composite gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
United Natural Foods, Ollie's Bargain, Smith & Wesson Brands And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded mostly lower, with the Nasdaq Composite dropping over 60 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Earnings Scheduled For December 6, 2022
Companies Reporting Before The Bell • AutoZone (NYSE:AZO) is projected to report quarterly earnings at $25.27 per share on revenue of $3.86 billion. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.